Amundi - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
Amundi ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,968,005
+7.2%
65,974
+46.4%
0.00%0.0%
Q2 2023$1,835,084
+188.3%
45,077
+153.5%
0.00%
Q1 2023$636,453
+0.2%
17,783
+5.0%
0.00%
Q4 2022$635,269
-55.5%
16,936
-27.7%
0.00%
-100.0%
Q3 2022$1,427,000
+110.8%
23,426
+120.9%
0.00%0.0%
Q2 2022$677,000
+74.5%
10,607
+80.2%
0.00%
Q1 2022$388,000
+103.1%
5,887
+175.5%
0.00%
Q4 2021$191,000
-23.0%
2,137
+15.8%
0.00%
Q3 2021$248,0001,8460.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders